{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:03:42Z","timestamp":1761170622804,"version":"build-2065373602"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,21]]},"DOI":"10.7759\/cureus.95106","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:18Z","timestamp":1761100698000},"source":"Crossref","is-referenced-by-count":0,"title":["Prolonged Gastric Retention of Sodium Zirconium Cyclosilicate: A Case Report"],"prefix":"10.7759","author":[{"given":"Masafumi","family":"Yoshinaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwonil","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham DK","year":"2015","unstructured":"Packham DK, Rasmussen HS, Lavin PT, et al.. Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med. 2015, 372:222-31. 10.1056\/NEJMoa1411487","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.11.014","article-title":"Sodium zirconium cyclosilicate for management of hyperkalemia during spironolactone optimization in patients with heart failure","volume":"85","author":"Kosiborod MN","year":"2025","unstructured":"Kosiborod MN, Cherney DZ, Desai AS, et al.. Sodium zirconium cyclosilicate for management of hyperkalemia during spironolactone optimization in patients with heart failure. J Am Coll Cardiol. 2025, 85:971-84. 10.1016\/j.jacc.2024.11.014","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000586","article-title":"The association of heart failure and edema events between patients initiating sodium zirconium cyclosilicate or patiromer","volume":"5","author":"Desai NR","year":"2024","unstructured":"Desai NR, Kammerer J, Budden J, Olopoenia A, Tysseling A, Gordon A. The association of heart failure and edema events between patients initiating sodium zirconium cyclosilicate or patiromer. Kidney360. 2024, 5:1835-43. 10.34067\/KID.0000000586","journal-title":"Kidney360"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.70352\/scrj.cr.24-0123","article-title":"A case of sigmoid colon perforation associated with sodium zirconium cyclosilicate in a patient with advanced rectal cancer","volume":"11","author":"Kamiya T","year":"2025","unstructured":"Kamiya T, Miyake T, Inatomi O, Shimizu T. A case of sigmoid colon perforation associated with sodium zirconium cyclosilicate in a patient with advanced rectal cancer. Surg Case Rep. 2025, 11:24-0123. 10.70352\/scrj.cr.24-0123","journal-title":"Surg Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1137981","article-title":"Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease","volume":"10","author":"Nakayama T","year":"2023","unstructured":"Nakayama T, Yamaguchi S, Hayashi K, et al.. Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease. Front Med (Lausanne). 2023, 10:1137981. 10.3389\/fmed.2023.1137981","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.08.016","article-title":"Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review","volume":"126","author":"Harel Z","year":"2013","unstructured":"Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. Am J Med. 2013, 126:264.e9-24. 10.1016\/j.amjmed.2012.08.016","journal-title":"Am J Med"},{"key":"ref7","article-title":"Calcium polystyrene sulfonate-induced gastrointestinal tract necrosis and perforation","volume":"82","author":"Buraphat P","year":"2019","unstructured":"Buraphat P, Niyomnaitham S, Pongpaibul A, Maneerattanaporn M. Calcium polystyrene sulfonate-induced gastrointestinal tract necrosis and perforation. Acta Gastroenterol Belg. 2019, 82:542-3.","journal-title":"Acta Gastroenterol Belg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2018.04.008","article-title":"Sodium polystyrene sulfonate induced intestinal necrosis; a case report","volume":"26","author":"Almulhim AS","year":"2018","unstructured":"Almulhim AS, Hall E, Mershid Al Rehaili B, Almulhim AS. Sodium polystyrene sulfonate induced intestinal necrosis; a case report. Saudi Pharm J. 2018, 26:771-4. 10.1016\/j.jsps.2018.04.008","journal-title":"Saudi Pharm J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-024-08979-1","article-title":"Risk of serious adverse gastrointestinal events with potassium binders in hospitalized patients: a national study","volume":"40","author":"Holleck JL","year":"2025","unstructured":"Holleck JL, Han L, Skanderson M, et al.. Risk of serious adverse gastrointestinal events with potassium binders in hospitalized patients: a national study. J Gen Intern Med. 2025, 40:518-24. 10.1007\/s11606-024-08979-1","journal-title":"J Gen Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/aimcc.2023.0888","article-title":"Lokelma\u2019s interaction with computed tomography angiography","volume":"2","author":"Boss R","year":"2023","unstructured":"Boss R, Nguyen M, Wahi-Gururaj S. Lokelma\u2019s interaction with computed tomography angiography. Ann Intern Med Clin Cases. 2023, 2:11. 10.7326\/aimcc.2023.0888","journal-title":"Ann Intern Med Clin Cases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-021-00607-9","article-title":"Radiopacity of sodium zirconium cyclosilicate on CT imaging","volume":"10","author":"Kolesnik M","year":"2021","unstructured":"Kolesnik M, Berezovsky D, Sayegh M, Samarneh M. Radiopacity of sodium zirconium cyclosilicate on CT imaging. CEN Case Rep. 2021, 10:559-62. 10.1007\/s13730-021-00607-9","journal-title":"CEN Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2284839","article-title":"Radiopacity of sodium zirconium cyclosilicate in computed tomography: a case of a patient with hyperkalemia and kidney disease","volume":"45","author":"Angioi A","year":"2023","unstructured":"Angioi A, Floris M, Lepori N, Cabiddu G, Pani A. Radiopacity of sodium zirconium cyclosilicate in computed tomography: a case of a patient with hyperkalemia and kidney disease. Ren Fail. 2023, 45:2284839. 10.1080\/0886022X.2023.2284839","journal-title":"Ren Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6004323","article-title":"Upper gastrointestinal bleeding secondary to sodium polystyrene sulfonate use: a rare adverse effect of commonly prescribed treatment","volume":"2024","author":"Shariff H","year":"2024","unstructured":"Shariff H, Naidoo S, Ghafari G, Li H, Devi M, Kumar K. Upper gastrointestinal bleeding secondary to sodium polystyrene sulfonate use: a rare adverse effect of commonly prescribed treatment. Case Rep Gastrointest Med. 2024, 2024:6004323. 10.1155\/2024\/6004323","journal-title":"Case Rep Gastrointest Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref15","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig SC","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992, 49:2229-32.","journal-title":"Am J Hosp Pharm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367292-prolonged-gastric-retention-of-sodium-zirconium-cyclosilicate-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:21Z","timestamp":1761100701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367292-prolonged-gastric-retention-of-sodium-zirconium-cyclosilicate-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.95106","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}